↓ Skip to main content

Dove Medical Press

Emerging therapeutic options for acute migraine: focus on the potential of lasmiditan

Overview of attention for article published in Neuropsychiatric Disease and Treatment, March 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter
6 X users
facebook
1 Facebook page

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
49 Mendeley
Title
Emerging therapeutic options for acute migraine: focus on the potential of lasmiditan
Published in
Neuropsychiatric Disease and Treatment, March 2014
DOI 10.2147/ndt.s25531
Pubmed ID
Authors

Paul B Rizzoli

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 49 100%

Demographic breakdown

Readers by professional status Count As %
Other 8 16%
Student > Ph. D. Student 6 12%
Student > Doctoral Student 5 10%
Student > Bachelor 4 8%
Researcher 3 6%
Other 10 20%
Unknown 13 27%
Readers by discipline Count As %
Medicine and Dentistry 22 45%
Agricultural and Biological Sciences 3 6%
Pharmacology, Toxicology and Pharmaceutical Science 3 6%
Nursing and Health Professions 2 4%
Chemistry 2 4%
Other 4 8%
Unknown 13 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 June 2016.
All research outputs
#8,343,963
of 25,584,565 outputs
Outputs from Neuropsychiatric Disease and Treatment
#1,074
of 3,120 outputs
Outputs of similar age
#76,538
of 236,752 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#20
of 57 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 3,120 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 236,752 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 57 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.